Recurrent ischaemic events following thrombosis have been pathophysiologically linked to
**Core Concept**
Lipoprotein(a) [Lp(a)] is a type of lipoprotein that plays a significant role in lipid metabolism. Elevated levels of Lp(a) have been associated with an increased risk of atherosclerotic cardiovascular disease, including myocardial infarction and stroke, due to its prothrombotic properties.
**Why the Correct Answer is Right**
Lp(a) contains an additional apolipoprotein(a) component that shares structural homology with plasminogen. This similarity enables Lp(a) to compete with plasminogen for binding to fibrin clots, thereby inhibiting fibrinolysis and potentially leading to recurrent ischemic events. High levels of Lp(a) have been linked to an increased risk of thrombotic events, including myocardial infarction and stroke, by promoting clot formation and stability.
**Why Each Wrong Option is Incorrect**
**Option A:** Antibodies to thrombolytic agents would not directly contribute to recurrent ischemic events following thrombosis. While immune responses to thrombolytic agents could potentially influence bleeding risk, they are not directly linked to thrombotic events.
**Option B:** Fibrinopeptide A is a marker of thrombin activity, but it is not directly involved in the pathogenesis of recurrent ischemic events. Elevated fibrinopeptide A levels indicate thrombin activity, but they do not contribute to the underlying mechanisms leading to recurrent ischemic events.
**Option D:** Triglycerides are a type of lipoprotein that can contribute to cardiovascular disease, but they are not directly linked to recurrent ischemic events following thrombosis. Elevated triglyceride levels are more commonly associated with pancreatitis and atherosclerotic disease, rather than thrombotic events.
**Clinical Pearl / High-Yield Fact**
Elevated levels of Lp(a) are a significant risk factor for atherosclerotic cardiovascular disease, including myocardial infarction and stroke. Monitoring and managing Lp(a) levels can help identify individuals at increased risk of these events.
**β Correct Answer: C. Lipoprotein A**